at the same time & to be fair IMO the stopping of the trial was prudent. They got to see the safety of the drug was still very much in tack + prob picked up on one or two goodies that now allow them to have an even better chance of success IMO. Guess we will see in a paper of sorts down the road.
Also to be fair this FDA meeting is no tiny thing,it is very positive & part of the process that may get us going on that phase 3 as early as Sept/October IMO.
If or when we get the go ahead it will be a good day.
Think some of us can start to chill for the summer or at least until FDA meet in August :)
glta
